A Scottish clinical and translational informatics company has announced it is part of a consortium selected to deliver a digital research environment based on its AnalytiXagility informatics platform to one of the Netherland’s most prestigious university medical centres, with the aim of facilitating biomedical research on an unprecedented scale. The consortium, incorporating Aridhia, ICT service provider Vancis, and clinical datasets …
Cancer Patients may not need a scan due to New Blood Test
View PostArtificial Intelligence to be used in a study for Alzheimer’s Drug Development
View PostNorwegian Government increases Precision Medicine state funding to NOK 61,3 Million
View PostOutcomes for Cancer Patients improve due to Precision Medicine Treatments
View PostNational Institutes of Health funds study to progress Precision Medicine for Diabetes
View PostTargeted Drug to treat Lung Cancer approved for NHS use in England
View PostCancer Professionals suffering higher levels of Burnout due to Covid-19
View PostNovo Nordisk Foundation Supports New National Genome Centre
View PostThe UK has sequenced 100,000 whole genomes in the NHS
View PostGenomic Medicine Sweden receives SEK 43,8 million from Vinnova
View PostCOLLABORATION BEYOND BENELUX
View PostNordic Precision Medicine Forum encourages smart-thinking, innovation and collaboration.
View PostNew CEO at Genomics England
View PostPMF and PERMIDES collaboration
View PostLaunched Finnish study first of its type
View PostSciLifeLab awards sequencing grants
View PostUniversal Diagnostics partner with NHS Trust to analyse screening test
View PostBelgian diagnostics firm achieve liquid biopsy certification
View PostEuropean funding awarded to liquid biopsy and MRI consortium
View PostHummingbird and Saarland university confirm microRNA biomarker study
View PostCase study reveals NGS can speed-up lung cancer screening process
View PostPopular health-tracking device to be used in US big-data project
View PostNew glossary will improve PM communication, says ESMO
View PostFIMM extend collaboration with liquid handling firm
View PostEU funded initiative aims to apply big-data to cardiovascular health
View PostNew editor appointment at Precision Medicine Forum
View PostINTERMOUNTAIN HEALTHCARE ANNOUNCES PRECISION HEALTH RESEARCH ENDEAVORS WITH 10X GENOMICS
View PostStudy by New York Genome Center and IBM Demonstrates Potential for AI
View PostNew funding scheme for SMEs developing personalised medicine products and solutions
View PostNew research program in personalized medicine dedicated to cancer
View PostAll of Us Research Program Name New Chief Engagement Officer
View PostAMRA announce $9m funding
View PostHudsonAlpha and St. Jude Children’s Research Hospital awarded $14.3 million grant
View PostNational Danish Strategy for Personalized Medicine
View PostPrime Minister Opens £42m Biodata Innovation Centre and New Sequencing Facility
View PostAgendia’s proven breast cancer recurrence assay, MammaPrint, now available in the Middle East
View PostGenomics Medicine Ireland Raises $40 Million in Series A Funding
View PostPMI Cohort Program announces new name: the All of US Research Program
View PostIBM and Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service
View PostDignity Health and Catholic Health Joint Initiatives – Precision Medicine Program in the U.S.
View Post£18m lab complex will discover the clues to individuals’ illnesses
View PostProfessor Ewan Birney appointed to the Genomics England Board
View PostDNA Have Your Say – Project Launched on Genetic Info Sharing
View PostNIH funds biobank to support Precision Medicine Initiative Cohort Program
As part of President Obama’s Precision Medicine Initiative (PMI), the National Institutes of Health will award $142 million over five years to the Mayo Clinic, Rochester, Minnesota, to establish the world’s largest research-cohort biobank for the PMI Cohort Program, a longitudinal research study which aims to enroll 1 million or more U.S. participants to advance precision medicine. The award will …
NIH appoints Patricia Flatley Brennan, R.N., Ph.D., to lead the National Library of Medicine
Intermountain Healthcare and the Stanford Genome Technology Center (SGTC) have established a new collaborative research program..
Personal Genome Diagnostics names industry veteran Douglas Ward as Chief Executive Officer
Intermountain Healthcare and the Stanford Genome Technology Center (SGTC) have established a new collaborative research program..
HudsonAlpha Foundation establishes neurological disease research fund
Huntsville, Ala. — The HudsonAlpha Foundation has established the Memory and Mobility (M&M) Fund for neurological disease research. The M&M fund will support HudsonAlpha Institute for Biotechnology’s current and future neurological disease research. The first project will be to sequence the genomes of 1,500 patients with Alzheimer and Alzheimer-related dementia. “We have an unprecedented opportunity to access this data set …
Intermountain Precision Genomics and Stanford Genome Technology Form Clinical Genomics Partnership
Intermountain Healthcare and the Stanford Genome Technology Center (SGTC) have established a new collaborative research program..
- Page 1 of 2
- 1
- 2